Picture of ENvue Medical logo

FEED — ENvue Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Nanovibronix Says Shifting Majority Of Manufacturing Operations To Singapore To Allow Scalability Increase Efficiency, Address Potential Supply Chain Delays

June 29 (Reuters) - Nanovibronix Inc  NAOV.O :
    * NANOVIBRONIX - SHIFTING MAJORITY OF MANUFACTURING
OPERATIONS TO
SINGAPORE TO ALLOW SCALABILITY INCREASE EFFICIENCY AND ADDRESS
POTENTIAL SUPPLY CHAIN DELAYS
    * NANOVIBRONIX INC - TRANSITION EXPECTED TO BE COMPLETED IN
NEXT
FEW MONTHS
    * NANOVIBRONIX - EXPECT FULL EFFECTS OF MOVE TO GAIN
TRACTION AS
WE APPROACH END OF 2022 AND HEAD INTO 2023

Source text for Eikon:  ID:nBw5BwK1Ma 
Further company coverage:  NAOV.O

Recent news on ENvue Medical

See all news